| Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis C Fagundes, MN Pépin, M Guevara, R Barreto, G Casals, E Solà, ... Journal of hepatology 57 (2), 267-273, 2012 | 283 | 2012 |
| Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo AK Madiraju, Y Qiu, RJ Perry, Y Rahimi, XM Zhang, D Zhang, ... Nature medicine 24 (9), 1384-1394, 2018 | 263 | 2018 |
| Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis D Oró, T Yudina, G Fernández-Varo, E Casals, V Reichenbach, G Casals, ... Journal of hepatology 64 (3), 691-698, 2016 | 212 | 2016 |
| ARFI, FibroScan®, ELF, and their combinations in the assessment of liver fibrosis: a prospective study G Crespo, G Fernández-Varo, Z Mariño, G Casals, R Miquel, SM Martínez, ... Journal of hepatology 57 (2), 281-287, 2012 | 207 | 2012 |
| Cerium oxide nanoparticles: advances in biodistribution, toxicity, and preclinical exploration E Casals, M Zeng, M Parra‐Robert, G Fernández‐Varo, M Morales‐Ruiz, ... Small 16 (20), 1907322, 2020 | 136 | 2020 |
| Hypoxia induces B-type natriuretic peptide release in cell lines derived from human cardiomyocytes G Casals, J Ros, A Sionis, MM Davidson, M Morales-Ruiz, W Jiménez American Journal of Physiology-Heart and Circulatory Physiology 297 (2 …, 2009 | 109 | 2009 |
| Long-term remission and recurrence rate in a cohort of Cushing’s disease: the need for long-term follow-up G Aranda, J Enseñat, M Mora, M Puig-Domingo, MJ Martínez de Osaba, ... Pituitary 18, 142-149, 2015 | 107 | 2015 |
| Apelin mediates the induction of profibrogenic genes in human hepatic stellate cells P Melgar-Lesmes, G Casals, M Pauta, J Ros, V Reichenbach, R Bataller, ... Endocrinology 151 (11), 5306-5314, 2010 | 87 | 2010 |
| Hypoxia and proinflammatory factors upregulate apelin receptor expression in human stellate cells and hepatocytes P Melgar-Lesmes, M Pauta, V Reichenbach, G Casals, J Ros, R Bataller, ... Gut 60 (10), 1404-1411, 2011 | 85 | 2011 |
| Investigation of endogenous corticosteroids profiles in human urine based on liquid chromatography tandem mass spectrometry J Marcos, N Renau, G Casals, J Segura, R Ventura, OJ Pozo Analytica chimica acta 812, 92-104, 2014 | 79 | 2014 |
| Prevention of fibrosis progression in CCl4-treated rats: role of the hepatic endocannabinoid and apelin systems V Reichenbach, J Ros, G Fernandez-Varo, G Casals, P Melgar-Lesmes, ... Journal of Pharmacology and Experimental Therapeutics 340 (3), 629-637, 2012 | 78 | 2012 |
| Measurement and clinical usefulness of bilirubin in liver disease AR Guerra Ruiz, J Crespo, RM López Martínez, P Iruzubieta, ... Advances in Laboratory Medicine/Avances en Medicina de Laboratorio 2 (3 …, 2021 | 71 | 2021 |
| Evaluation of a new ultrasensitive assay for cardiac troponin I G Casals, X Filella, JL Bedini Clinical biochemistry 40 (18), 1406-1413, 2007 | 70 | 2007 |
| Intrinsic and extrinsic properties affecting innate immune responses to nanoparticles: the case of cerium oxide E Casals, MF Gusta, J Piella, G Casals, W Jiménez, V Puntes Frontiers in immunology 8, 970, 2017 | 63 | 2017 |
| Risk factors for a low linezolid trough plasma concentration in acute infections L Morata, M Cuesta, JF Rojas, S Rodriguez, M Brunet, G Casals, N Cobos, ... Antimicrobial agents and chemotherapy 57 (4), 1913-1917, 2013 | 63 | 2013 |
| Cerium oxide nanoparticles improve liver regeneration after acetaminophen-induced liver injury and partial hepatectomy in rats B Córdoba-Jover, A Arce-Cerezo, J Ribera, M Pauta, D Oró, G Casals, ... Journal of nanobiotechnology 17, 1-12, 2019 | 57 | 2019 |
| Cerium oxide nanoparticles: a new therapeutic tool in liver diseases G Casals, M Perramón, E Casals, I Portolés, G Fernández-Varo, ... Antioxidants 10 (5), 660, 2021 | 54 | 2021 |
| Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease S Carvajal, M Perramón, D Oró, E Casals, G Fernández-Varo, G Casals, ... Scientific reports 9 (1), 12848, 2019 | 54 | 2019 |
| Bespoken nanoceria: an effective treatment in experimental hepatocellular carcinoma G Fernández‐Varo, M Perramón, S Carvajal, D Oró, E Casals, L Boix, ... Hepatology 72 (4), 1267-1282, 2020 | 50 | 2020 |
| Cortisol measurements in Cushing's syndrome: immunoassay or mass spectrometry? G Casals, FA Hanzu Annals of laboratory medicine 40 (4), 285-296, 2020 | 49 | 2020 |
